What to Look for in the Smith & Wesson Earnings Report
Smith & Wesson is scheduled to release its fiscal fourth-quarter earnings report after the markets close Thursday.
All Work
Chris Lange
PSAV Cuts Expected Price Range for IPO
PSAV has lowered its expected price range to $12 to $13 per share from $14 to $17, for more than 14 million shares.
Tonix Pharmaceuticals Prices Secondary Offering
Shares of Tonix Pharmaceuticals slid in Thursday’s session after the company announced the pricing of its secondary offering.
Kroger Not Held Down by Mixed Q1 Earnings
Kroger Co. (NYSE: KR) reported mixed fiscal first-quarter financial results before the markets opened on Thursday.
What to Expect From Oracle Earnings
Oracle is set to report its fiscal fourth-quarter financial results after the markets close on Thursday.
How Poor Guidance Sank Jabil Circuit
Jabil Circuit reported mixed fiscal third-quarter financial results after markets closed on Wednesday.
SEC Hands Out Insider Charges to Fund Managers and Former Govt Official
The SEC has announced insider trading charges against two hedge fund managers and a former government official accused of deceptively obtaining confidential information from the FDA.
What to Look for in Rite Aid Earnings
Rite Aid is set to release its fiscal first-quarter financial results before the markets open on Thursday.
6 Biopharma Movers Making a Run on Wednesday
24/7 Wall St. has picked out the biggest movers and winners on Wednesday, particularly biopharma companies making serious runs in the session.
What to Expect From Kroger Earnings
Kroger is scheduled to report its fiscal second-quarter financial results before the markets open on Thursday.
Does Whole Foods Face Systemic FDA Warnings?
Whole Foods Market is under fire by federal regulators after an inspection of its food processing operations conducted back in February.
Dataram Moves to Acquire US Gold Corp
Dataram Corp. (NASDAQ: DRAM) has watched its shares fall over the course of Tuesday following the announcement of an acquisition. The company recently announced that it has entered into a definitive agreement to acquire…
How Analysts View LinkedIn After the Microsoft Buyout News
Microsoft has announced early that it would acquire LinkedIn. 24/7 Wall St. put together a montage of what analysts are saying about LinkedIn.
Revance Therapeutics Drops on Missed Late Stage Results
Revance Therapeutics hit a new 52-week low in Tuesday’s session following the release of its late stage trial results.
Why Infinity Pharmaceuticals Crashed
Though Infinity Pharmaceuticals announced that its DYNAMO study met its primary endpoint of overall response rate, the stock was still way down on the day for other reasons.
Zimmer Biomet Prices Secondary Offering
Zimmer Biomet saw its shares slide in Tuesday's session after the company announced the pricing of its previously disclosed underwritten secondary offering.
NXP Semiconductors Initiates Plan for Key Asset Divestiture
NXP Semiconductors traded down slightly Tuesday morning after the announcement that it will divest its Standard Products business to a consortium of financial investors.
Pfizer and Shire Move on IBD License Agreement
Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.
SEC Settles Fraud Charges With California Muni Advisors
The U.S. Securities and Exchange Commission (SEC) recently announced that two California-based municipal advisory firms and their executives have agreed to settle charges that they used deceptive practices when soliciting the business of five…
PointClickCare Prepares for IPO
PointClickCare has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).